Related by context. All words. (Click for frequent words.) 70 protein therapeutics 67 monoclonal antibodies 65 biotherapeutics 65 therapeutics 64 recombinant protein 64 biotherapeutic 63 biopharmaceuticals 63 recombinant proteins 62 therapeutic antibodies 62 therapeutic monoclonal antibodies 62 PROfusion 61 small molecule 61 polyclonal antibodies 60 therapeutic antibody 59 siRNA therapeutics 59 biologics 59 novel peptide 59 transgenic animals 59 LEX System 59 mAbs 59 chemotherapeutics 59 biologic therapies 59 humanized antibodies 59 antibody therapeutics 59 therapeutic monoclonal antibody 59 proteins peptides 58 therapeutic peptides 58 humanized monoclonal antibodies 58 AAV vector 58 siRNAs 58 antiviral therapeutics 58 small molecule inhibitors 58 recombinant protein therapeutics 58 stem cell therapeutics 58 siRNA therapeutic 58 Factor VIIa 58 recombinant antibodies 58 Phage Pharmaceuticals 57 recombinant 57 ESBA# 57 Anticalins R 57 mammalian cell 57 Scil Proteins 57 AAV vectors 57 PEGylation 57 rxRNA 57 PEGylated 57 biocatalysts 57 fusion proteins 57 lentiviral vectors 57 antibody 57 Factor IX 57 Homspera TM 57 IFN Beta CTP 56 Nanobodies 56 Pichia pastoris 56 recombinant human 56 Fc fusion protein 56 chemical entities NCEs 56 proteins 56 preclinical 56 siRNA delivery 56 antibody fragments 56 adrenal steroid hormones 56 anticancer drugs 56 RNAi compounds 56 GelSite R polymer 56 immunotherapeutics 56 enzymes 56 regenerative therapies 56 sd rxRNA 56 Symphogen 56 siRNA 56 tumor specific antigen 56 Nanobody ® 56 biologic 56 biomarker discovery 56 lentiviral vector 56 LentiVector technology 56 gene silencing 56 CHO cells 56 biologic therapeutics 56 anticancer compounds 56 antisense drugs 55 anticancer therapies 55 monoclonal antibody 55 liposomal 55 MDRNA proprietary 55 antibody therapies 55 humanized antibody 55 cancer therapeutics 55 proteasome inhibitors 55 Nanobodies ® 55 peptides 55 anticancer agents 55 monoclonal 55 PER.C6 ® 55 novel therapeutics 55 rxRNA compounds 55 novel peptides 55 tranilast 55 Bioral 55 selective inhibition 55 cancer immunotherapies 55 short interfering RNA 55 molecularly targeted 55 recombinant Factor VIII 55 Interferon alpha 55 Adenosine 55 zinc finger nucleases 55 Pfenex 55 Nautilus Biotech 55 deacetylase inhibitors 55 MEK inhibitors 55 Modigene 55 transgenic animal 55 liposomal delivery 55 Enkephalin 55 adenoviral 55 NovaBay Aganocide compounds 55 peptide antigens 55 DispersinB ® 55 anti CD3 55 Delta opioid receptor 54 targeting CD# 54 Sangamo ZFP technology 54 taxol 54 TÎ ² 4 54 GelSite polymer 54 DepoVax TM 54 Biolex 54 hESC derived 54 MAbs 54 PER.C6 ® cell 54 AAG geldanamycin analog 54 diagnostic assays 54 kinase inhibitors 54 RNAi 54 A3 adenosine receptor 54 immunotherapeutic 54 antibody fragment therapeutics 54 microtubule inhibitor 54 XmAb ® 54 MTP inhibitor 54 biomarkers 54 antisense oligonucleotides 54 Vidofludimus 54 anticoagulant reversing agent 54 human hepatocytes 54 cytotoxic 54 Onconase 54 Biopump 54 bioactive 54 antibody reagents 54 peptide 54 small molecule agonists 54 Receptors GPCRs 54 interferon beta 54 Fleximer R 54 NexACT 54 vinca alkaloid 54 GPR# agonists 54 therapeutic 54 calcitonin 54 DNA plasmids 54 histone methyltransferases HMTs 54 Monoclonal antibodies 54 hedgehog pathway 54 GeneICE 54 antibodies 54 ZFNs 54 biotherapies 54 MAb 54 microRNA 54 novel antibody therapeutics 54 Tranzyme 54 G Protein Coupled 54 polyketides 54 ZFP TFs 54 nucleic acids 54 Fc fusion proteins 54 Adnectin 54 anticancer therapeutics 54 antibody fragment 54 encapsulates siRNAs 54 preclinical studies 54 anticancer agent 54 virus AAV 54 viral vectors 53 bioprocesses 53 Myocet 53 synthetic peptides 53 Ambrx 53 MAXY VII 53 Curaxin 53 CEQ# 53 secreted proteins 53 HCV protease inhibitors 53 novel anticancer 53 aptamers 53 stable nucleic acid 53 ENMD # 53 DsiRNA 53 ZFP transcription factors 53 LentiVector 53 epigenetic enzymes 53 GPCRs 53 recombinant antibody 53 RNAi therapeutic 53 ZFP technology 53 Pfenex Expression Technology 53 NTDDS 53 inflammatory diseases 53 biopharmaceutical 53 Civacir 53 RECOTHROM R 53 bioactive molecules 53 anti infective treatments 53 therapeutic mAbs 53 pharmacological chaperone 53 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 53 plasmid DNA 53 THR beta agonist 53 SMARTICLES ® 53 LNP formulations 53 avian transgenic 53 Liprotamase 53 transfection reagents 53 Nanobody 53 histone deacetylase HDAC inhibitors 53 carbohydrate polymer 53 hyperimmune products 53 HQK 53 Squalamine 53 topical formulations 53 novel RNAi therapeutics 53 NYSE Amex PBTH 53 chemotherapeutic agents 53 oncolytic 53 RNA antagonist 53 hyaluronidase rHuPH# 53 Curaxins 53 Epitomics 53 novel immunotherapies 53 stem cell differentiation 53 Virulizin 53 Chinese hamster ovary 53 nanomedicines 53 PROLOR 53 bioactive lipids 53 CDK inhibitors 53 small molecule therapeutics 53 histone deacetylase inhibitor 53 protein 53 selective androgen receptor modulators 53 Adenosine Therapeutics 53 recombinant therapies 53 NPC 1C 53 JAK2 inhibitor 53 FAAH 53 monoclonals 53 kinase inhibitor 53 shRNA libraries 53 immunotoxins 53 recombinant vaccines 53 OvaRex R 53 siRNA sequences 53 XmAb 53 CD# antibody [001] 53 peptide therapeutics 53 vaccine GRNVAC1 53 transfection 53 recombinant albumin 53 histone deacetylase inhibitors 53 Aganocide ® 53 biosurgical 53 RNAi therapeutics 53 epothilone 53 systemic RNAi 53 molecular biomarkers 53 Novosom 53 antitumor 53 Phylomer 53 uricase 53 DOS# 53 humanized anti 53 ddRNAi 52 therapies 52 Locked Nucleic Acid LNA 52 dAbs 52 pegylated 52 Zysolin TM 52 recombinant Factor 52 vivo 52 iPSC 52 Fibroblast Growth Factor Receptor 52 Fc receptor 52 MAXY G# 52 antisense inhibitor 52 LNPs 52 human parthenogenetic stem 52 HepaGam B 52 enzyme inhibitor 52 biologicals 52 IAP inhibitor 52 oncolytic viruses 52 biocatalysis 52 GlycoPEGylation TM technologies 52 L DOS# 52 Litx 52 immune modulation 52 ZFN technology 52 Hsp# inhibitors 52 Preclinical studies suggest 52 miRNAs 52 TLR9 agonists 52 vivo validation 52 ALN TTR 52 immune modulators 52 juvenile chondrocytes 52 CTLA4 Ig 52 tkRNAi 52 renin inhibitor 52 humanized monoclonal antibody 52 PI3K inhibitors 52 Fleximer 52 mammalian cells 52 secondary metabolites 52 BioSilicon TM 52 PEGylation technology 52 recombinant adeno associated 52 antitumoral 52 tafamidis 52 monoclonal antibody therapeutics 52 VA# [002] 52 ZFP TF 52 synthetic siRNA 52 SCD1 52 nanoviricides 52 RNA interference RNAi therapeutics 52 TNFa 52 Flt3 52 immune stimulatory 52 ErbB3 HER3 52 TELINTRA 52 SARMs 52 MEK inhibitor 52 bioactive compounds 52 microRNA therapeutics 52 mucosal vaccines 52 DiLA2 52 Pancreate 52 Tß4 52 bioactivity 52 TRV# [001] 52 transfection reagent 52 CRD5 52 bioscavenger 52 targeted radiotherapeutic 52 DispersinB R 52 JAK#/JAK# 52 aminoglycosides 52 ADAMTS# 52 protein purification 52 antisense 52 Tβ4 52 Rasagiline 52 functional genomics 52 Kapa Biosystems 52 predictive toxicology 52 preclinical toxicology 52 CBLC# 52 diagnostic biomarkers 52 bio therapeutics 52 novel antiviral therapeutics 52 hepatocyte 52 GTC recombinant human 52 immunological diseases 52 Adnectins 52 Anidulafungin 52 preclinical compounds 52 Mycograb 52 small interfering RNA 52 partial agonist 52 monoclonal antibodies mAbs 52 nitric oxide donating 52 miRNA 52 PEGPH# 52 ANAVEX #-# [003] 52 exon skipping 52 kidney urologic 52 prodrugs 52 cGMP manufacture 52 lysozyme 52 isoform selective 52 peptide fragments 52 echinocandin 52 KineMed 52 CB2 receptor 52 JAK3 52 aptamer therapeutics 52 Monoclonal antibody 52 autologous cells 52 monoclonal antibody therapies 52 potently inhibit 52 Scancell 52 SNALP technology 52 iPSC technology 52 oncology therapeutics 52 interferons 52 multitargeted 52 lipidoid 52 otelixizumab 52 Anticalins 52 meganucleases 52 RNA interference 52 Aviptadil 52 RNAi therapeutic targeting 52 hES cells 52 rxRNA TM compounds 52 bispecific antibody 52 Anticalins ® 52 synthetic peptide 52 interferon alpha 52 HSP# inhibitors 52 salmon calcitonin 52 CompoZr 52 Th2 cytokines 52 microRNAs 52 glucagon receptor 52 targeting PCSK9 52 Affibody ® molecules 52 recombinant polyclonal antibodies 52 siRNA compounds 52 Olaparib 52 XmAb ™ 52 therapeutic peptide 52 Ii Key 52 Dalbavancin 52 novel immunomodulatory 52 Dowpharma 52 chemotherapeutic drugs 52 Quark Biotech Inc. 52 CXCR4 receptor 52 splice variants 52 novel therapeutic antibodies 52 recombinant spider silk 52 potent cytotoxic 52 CCR9 antagonist 52 novel immunotherapeutic 52 transgenesis 52 somatostatin analogue 51 acetylcholinesterase AChE 51 Anticalin R 51 Vaccinex 51 lipid nanoparticle 51 cardiometabolic disorders 51 microbial fermentation 51 orally bioavailable 51 resolvins 51 RhuDex ® 51 ProtAffin 51 TLR8 51 Cylene 51 deCODE chemistry 51 genOway 51 rHuPH# 51 HSP# inhibitor 51 CDP# 51 telomerase inhibitor 51 hydrolysates 51 Elafin 51 Panzem 51 vaccine adjuvant 51 IIB ActRIIB 51 EGF receptor 51 activin 51 JAK inhibitors 51 nanocarriers 51 Stapled Peptide 51 immunotherapeutic approaches 51 ADCC enhanced 51 Crop BioScience 51 polymerase inhibitors 51 peptide mimetics 51 MediVas 51 rFVIIIFc 51 pegylation 51 antisense drug 51 TKM ApoB 51 polymer conjugate technology 51 JAK3 inhibitor 51 Cethrin 51 antiviral compounds 51 glycosylation profile 51 inhibiting tumor 51 anti infective 51 orally dosed 51 Viprovex TM 51 GAP #B# 51 atacicept 51 systemic siRNA 51 butyrylcholinesterase 51 nicotinic acetylcholine receptor 51 RNA interference RNAi 51 vitamin D analogs 51 biased ligand 51 sphingolipid 51 metabolite identification 51 metalloenzymes 51 Vandetanib 51 tumor antigens 51 ApoB SNALP 51 novel anti infective 51 UltiMAb ® 51 BRAF kinase 51 non nucleoside 51 GRNVAC1 51 rxRNA ™ compounds 51 NIC5 51 immunotherapy 51 glycosylated 51 proprietary PEGylation 51 Prodarsan ® 51 plasma proteins 51 protein kinase inhibitor 51 ViaCyte 51 membrane receptors 51 NP2 51 glioma cells 51 soluble proteins 51 #beta HSD1 51 anionic backbone 51 KL4 surfactant 51 Romidepsin 51 sodium thiosulfate STS 51 Lixivaptan 51 FoldRx 51 neural stem cell 51 secretory pathway 51 ulimorelin 51 HTS assay 51 immunotherapies 51 Transfection Reagent 51 investigational humanized monoclonal antibody 51 MUC1 51 FLT3 51 DepoVax ™ 51 Campath alemtuzumab 51 nucleoside analogs 51 Etubics 51 selectively inhibit 51 Nexavar ® 51 lipid particles 51 Receptos 51 p# inhibitors 51 catalytic antioxidant compounds 51 factor G CSF 51 VEGF inhibitors 51 anti angiogenic agent 51 hybridoma cell 51 CB1 antagonists 51 humanized monoclonal 51 TransMolecular 51 immune modulating 51 biomarker assays 51 Phylomer ® 51 Prodarsan R 51 UsiRNAs 51 Celator 51 Mipomersen 51 telomerase therapeutic 51 tiapamil 51 shRNA 51 Dyax phage display 51 Ramoplanin 51 thymosin beta 4 51 BioWa 51 HepDirect R 51 affinity ligands 51 FVIIa 51 potent inhibitors 51 vaccine antigens 51 hybridoma 51 Therapeutic antibodies 51 New Chemical Entities 51 P#X# 51 AMPK activators 51 Gleevec resistant 51 anticancer 51 Phase IIb clinical trials 51 biologically active 51 eligen 51 BioSeek 51 IX Fc fusion 51 Human cl 51 nanoparticle formulation 51 Micropump 51 covalent drugs 51 ZFN TM 51 angiogenesis inhibitor 51 sphingolipids 51 Atrigel 51 recombinant factor VIIa 51 oxazolidinone 51 synthetic retinoid 51 TGF alpha 51 biodefense vaccines 51 Cyclosert TM 51 anti CD3 antibody 51 GM CSF 51 aTyr Pharma 51 FK# 51 Selexis 51 pDNA vaccines 51 Cyclosert 51 monoclonal antibody mAb 51 Hsp# inhibitor 51 PDGF receptor 51 GHRH 51 GPCR targets 51 receptor inhibitor 51 cancer immunotherapy 51 engineered proteases 51 bone morphogenetic proteins 51 chimeric monoclonal antibody 51 TOPIGEN 51 OncoVEX 51 receptors PPARs 51 oligonucleotide therapeutics 51 ocular diseases 51 Tumour Vascular Disrupting Agent 51 viral vector 51 biodegradable polymers 51 Vorinostat 51 NEUGENE R 51 biomanufacturing 51 adenovirus vector 51 molecules 51 Virulizin R 51 pro angiogenic 51 transgenic 51 viral antigen 51 Intarcia 50 trans splicing 50 Mesd 50 Hedgehog inhibitor 50 anti amnesic 50 CHO cell 50 fusion protein 50 depsipeptide 50 Soliris eculizumab 50 ALN TTR# 50 AtuRNAi 50 Regado Biosciences 50 PharmFilm ® 50 Cdc7 50 SGLT inhibitors 50 Lentigen 50 affinity antibodies 50 PDE4 inhibitor 50 markets biosurgical 50 immunoregulatory 50 Cyclin E 50 Neose 50 Homspera ® 50 Pervasis 50 small molecule activators 50 romazarit 50 Tolerx 50 chronic inflammatory 50 glycobiology 50 anti CD# antibodies 50 Annexin A5 50 oral prodrug 50 biomarker 50 influenza vaccines 50 CENP E 50 cellular uptake 50 ALN PCS 50 nanomolar range 50 protein antigens 50 muscular dystrophies 50 liposomal formulation 50 Maxy G# 50 vascular disrupting agents 50 tumor necrosis factor 50 RONDEL ™ 50 Pazopanib 50 Inc. OTCBB IRBS 50 PhaseBio 50 Xanafide 50 Chrysalin 50 molecular chaperone 50 SERMs 50 pRNA 50 Semafore 50 buccal delivery 50 keratinocyte 50 Omacetaxine 50 immunomodulatory 50 liprotamase 50 TYZEKA 50 zinc finger nuclease 50 DXL# 50 ligand TRAIL 50 sd rxRNA compounds 50 vitro 50 epothilones 50 Belerofon 50 OxBC 50 Protein Kinase C 50 Anthim 50 MyVax R 50 eicosanoid 50 biobetter 50 miRNA therapeutics 50 Nasdaq ENZN 50 HepDirect 50 autoimmune indications 50 anidulafungin 50 mda 7 50 Hedgehog signaling pathway 50 GlycArt 50 chimeric protein 50 Anticalin ® 50 PolyTherics 50 ImmuneRegen BioSciences Inc. 50 HepDirect prodrug 50 effector function 50 SNALP 50 AAGP TM 50 interleukin IL -# 50 rFVIII 50 allosteric modulators 50 Juvaris 50 small molecule tyrosine 50 Exherin TM 50 PET tracers 50 HDAC inhibition 50 Aurora kinase 50 bioactives 50 lyophilized 50 mAb 50 vorinostat 50 FGFR 50 biodegradable nanoparticles 50 RNA silencing 50 CYT# potent vascular disrupting 50 YONDELIS 50 naturally occurring proteins 50 Urocidin 50 dSLIM 50 dihydrofolate reductase 50 SGLT2 inhibitors 50 nanobodies 50 DPX Survivac 50 enveloped viruses 50 Oncaspar 50 Eliezer Zomer Ph.D. 50 recombinant vaccine 50 neurotrophic factors 50 SCYNEXIS 50 Onalta 50 alglucosidase alfa 50 effector functions 50 DAVANAT 50 Symadex 50 alpha interferon 50 protease enzyme 50 EBx ® 50 antiviral cytokines 50 DHFR 50 proprietary DuraSite ® 50 Gefitinib 50 commercializing anti infective 50 IGF 1R 50 immunoregulation 50 DCVax 50 inhibit viral replication 50 rBChE 50 adenosine A2A 50 tubulin inhibitor 50 peptide hormone 50 Alfacell proprietary ribonuclease 50 oncolytic virus therapies 50 Sebivo 50 cell signaling pathways 50 SGLT2 50 histone deacetylase HDAC 50 topically delivered 50 BioVant 50 gene therapy 50 antisense therapeutics 50 Archemix 50 Cellcept 50 NexACT ® 50 immunotoxin 50 Charlesson 50 peptide hormones 50 OHR/AVR# 50 BAY #-# 50 fibrin sealant 50 insulin analogs 50 indibulin 50 cell transplantation 50 SRT# [003] 50 NanoCrystal technology 50 antibody cytokine 50 GelSite 50 bioactive compound 50 MP4 molecule 50 glycolipids 50 gene expression profiling 50 patented NanoStat TM 50 Poly ICR 50 factor VIIa 50 Amphotericin B 50 spermidine 50 Antisense 50 cytokine 50 omacetaxine 50 Elixir Pharmaceuticals 50 MOZOBIL 50 polyclonal antibody 50 Nasdaq MITI biopharmaceutical 50 phage display 50 treating neuropathic pain 50 erlotinib Tarceva 50 histone deacetylase HDAC inhibitor 50 targeted antifolate 50 NS5A 50 Aeolus Pharmaceuticals 50 ERYtech Pharma 50 Thrombin 50 bafetinib 50 ANTISENILIN ® 50 Minapharm 50 Novozymes Biopharma 50 immuno oncology 50 miR #a [002] 50 ZFN modified 50 Cethrin R 50 Captisol 50 lysosomal 50 selective inhibitors 50 ProMune 50 Homspera 50 molecular assays 50 induced pluripotent stem cells 50 vWF 50 sodium glucose transporter 50 oral anticancer 50 ribonucleic acid interference RNAi 50 Hsp# inhibition 50 OTCBB PYTO FWB ET6 50 Campath ® 50 androgen receptor AR 50 antagomirs 50 Exelixis compounds 50 TB4 50 GGF2 50 Sphingomab 50 PTP 1B 50 prostone 50 using Crucell PER.C6 50 naturally occurring protein 50 succinate 50 humanised monoclonal antibody 50 alfa interferon 50 Vascular Endothelial Growth 50 SGLT 50 recombinant DNA 50 clinical trials 50 Bendamustine 50 Anticalin 50 INT# [002] 50 IFN Beta 50 XP #L 50 recombinant fusion 50 induce apoptosis 50 tkRNAi technology 50 viral proteins 50 bryostatin 50 HDACs 50 Fabry Disease 50 lipid nanoparticles 50 regenerative medicine therapies 50 EBx 50 DNA gyrase 50 regenerative medicine 50 multi kinase inhibitor 50 HemoTech TM 50 proteases 50 casein kinase 50 Liposomal 50 REP# 50 hpSC 50 ghrelin receptor 50 gene expression 50 Logical Therapeutics 50 immune modulatory 50 Novasome R 50 Leukine ® 50 Galectin 50 adenoviral vectors 50 Myolimus 50 histone deacetylases 50 Robert L. Bratzler 50 anti CD3 monoclonal 50 BiTE antibody 50 IL# PE#QQR 50 hepatocytes 50 cyclin dependent kinase inhibitor 50 selective relaxant 50 Gamunex C 50 milatuzumab 50 nucleic acid 50 TIMERx 50 HDAC inhibitor 50 RNAi therapeutic targeting PCSK9 50 HuMax TAC 50 BNC# 50 integrin receptors 50 PGE2 50 Spiegelmers ® 50 bioprocess 50 intranasal delivery 50 PORxin TM 50 clinically validated targets 49 siRNAs targeting 49 proprietary Dicer Substrate Technology 49 Stapled Peptides 49 NanoTab 49 TRX1 49 hereditary emphysema 49 DNA methyltransferases 49 theranostic 49 protease inhibitors 49 MyoCell ® 49 Amunix 49 immunomodulators 49 biotechnologically 49 AMPAKINE 49 SGLT Inhibitors 49 DepoVax 49 Vilazodone 49 NAGS deficiency 49 lyophilized formulation 49 CRAC channel 49 TLR agonists 49 intracellular signaling pathways 49 enzyme cofactor 49 fusion inhibitor 49 Panzem R 49 porcine derived 49 CD# monoclonal antibody 49 Xcellerex 49 intravesical instillation 49 ACTCellerate 49 fermentative 49 recombinantly 49 Smac mimetics 49 EVIZON TM 49 BiTE 49 ATL# [001] 49 ZFP Therapeutic 49 PARP inhibitors 49 TRIOLEX 49 somatostatin 49 NuMimetic TM 49 bioavailability enhancement 49 ENaC 49 oligonucleotides 49 GlycoPEG GCSF 49 nucleotide analogs 49 diagnostic molecular imaging 49 Aptamer 49 generic biopharmaceuticals 49 PKCi 49 GDIR 49 autologous cell 49 ophthalmology oncology 49 ImaginAb 49 investigational therapies 49 biomarker identification 49 Carcinoid tumors 49 bioprocessing 49 NEUGENE 49 Guanilib 49 E2F 49 delta isoform 49 FluCide 49 octreotide 49 myelofibrosis polycythemia vera 49 Viprovex R 49 dendrimers 49 ES cells 49 Prolastin C